glp-1 agonists blindness risk GLP-1s are changing bodies… but what about the eyes? 👀 Here's what the current research shows: ▫ Rapid A1C reduction can trigger early worsening of DR (especially in moderate+ NPDR) ▫ More A Critical Eye on GLP-1

Research on Metabolism and Oxidative Processes Preclinical studies suggest that Delta Sleep-Inducing Peptide may influence mitochondrial respiration under stress conditions, potentially supporting oxidative phosphorylation even during oxygen deprivation

L-carnitine transports free fatty acids to the energy centers of the cells to mitochondria

Metabolic vulnerabilities of prostate cancer: diagnostic and therapeutic opportunities

It is a promising investigational amylin analog, not an approved therapy, and its gastric-emptying credentials are best described as mechanistically well-founded but not yet fully quantified in humans over time

Is CJC-1295 No DAC the same as Modified GRF (1-29)

Targeting survivin expression induces G2/M block and subsequent cell death involving mitochondrial pathway in myeloid leukemic cells